Transesophageal Atrial Pacing in Paroxysmal Supraventricular Tachycardia in Infants and Children
Yoshiki Fujiseki, Masahiko Okuno, Hidetoshi Fujino, Masanori Hattori, Kazuo Nonomura, Morimi Shimada
Abstract
Yoshiki Fujiseki, Masahiko Okuno, Hidetoshi Fujino, Masanori Hattori, Kazuo Nonomura, Morimi Shimada
Abstract
Abstract Fourteen patients with paroxysmal supraventricular tachycardia (PSVT) underwent serial electrophysiologic studies using transesophageal atrial pacing (EPS‐EP), to determine the predictive value of this method in the selection of antiarrhythmic therapy and to study the mechanism of the tachycardia. In each patient, PSVT could be reproducibly initiated by burst and/or programmed stimuli. After control EPS‐EP, the effects of several drugs (diltiazem, disopyramide, propranolol, digoxin, procainamide and verapamil) on the ability to initiate PSVT or to bring about “tachycardia zone” were examined. The mechanisms of PSVT were also investigated using an esophageal electrode, EPS‐EP, and Ca++‐antagonists. Drug responses were variable but in most cases tachycardia could not be initiated after drug administration. Four types of supraventricular tachycardia are described. In eight out of nine patients, good therapeutic control was obtained. This study shows that serial EPS‐EP can provide rapid identification of appropriate antiarrhythmic therapy, and is useful in studying the mechanism of PSVT.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Fourteen patients with paroxysmal supraventricular tachycardia (PSVT) underwent serial electrophysiologic studies using transesophageal atrial pacing (EPS‐EP), to determine the predictive value of this method in the selection of antiarrhythmic therapy and to study the mechanism of the tachycardia. In each patient, PSVT could be reproducibly initiated by burst and/or programmed stimuli. After control EPS‐EP, the effects of several drugs (diltiazem, disopyramide, propranolol, digoxin, procainamide and verapamil) on the ability to initiate PSVT or to bring about “tachycardia zone” were examined. The mechanisms of PSVT were also investigated using an esophageal electrode, EPS‐EP, and Ca++‐antagonists. Drug responses were variable but in most cases tachycardia could not be initiated after drug administration. Four types of supraventricular tachycardia are described. In eight out of nine patients, good therapeutic control was obtained. This study shows that serial EPS‐EP can provide rapid identification of appropriate antiarrhythmic therapy, and is useful in studying the mechanism of PSVT.
Key concepts: Medicine, Paroxysmal supraventricular tachycardia, Procainamide, Digoxin, Tachycardia, Verapamil, Supraventricular tachycardia, Disopyramide